COVID-19 Infections Not More Prevalent in IBD Patients

The Theory Past research has shown that there are certain individuals are genetically susceptible to IBD due to a dysregulated intestinal immune response to various environmental factors. In addition data on the immune response induced by SARS-CoV-2 or COVID-19 vaccines are less definitiveand potent...

Full description

Saved in:
Bibliographic Details
Published inHCPLive
Main Author Kenny, Walter
Format Trade Publication Article
LanguageEnglish
Published Cranbury MultiMedia Healthcare Inc 15.07.2022
Subjects
Coronaviruses
COVID-19 vaccines
Immunosuppressive agents
Infections
Inflammatory bowel disease
Pediatrics
Severe acute respiratory syndrome coronavirus 2
Tumor necrosis factor-TNF
Online AccessGet full text
ISSN2767-7168
2767-7168

Cover

More Information
Summary:The Theory Past research has shown that there are certain individuals are genetically susceptible to IBD due to a dysregulated intestinal immune response to various environmental factors. In addition data on the immune response induced by SARS-CoV-2 or COVID-19 vaccines are less definitiveand potentially not substantially different from what is seen in healthy subjects, with the possible exception being patients with IBD treated with anti-tumor necrosis factor (anti-TNF) treatments alone or in combination with other immunosuppressants. The study, "Risks of SARS-CoV-2 Infection and Immune Response to COVID-19 Vaccines in Patients With Inflammatory Bowel Disease: Current Evidence," was published online in Frontiers in Immunology.
ISSN:2767-7168
2767-7168